Want to see HK:2373 full AI Analyst Report?
Top Page
Beauty Farm Medical & Health Industry, Inc.
(2373)
Select Model
Select Model
Rating:68Neutral
Price Target:
HK$18.00
▼(-7.64% Downside)
Action:Reiterated
Date:09/19/26
The score is driven primarily by solid financial performance with improving margins and growth, partially offset by a sharp increase in leverage and some cash-flow metric uncertainty. Technicals are moderately supportive with improving near-term trend but a weaker long-term signal versus the 200-day average. Valuation is a key positive, with a low P/E and a solid dividend yield supporting upside/risk balance.
Positive Factors
Revenue Growth
Revenue expanded strongly from 2023 to 2025, including a sharp step-up in 2025. This indicates meaningful business growth and can strengthen operating scale, reinvestment capacity, and competitive position over the next several quarters, provided the higher growth level is maintained.
Negative Factors
Rising Leverage
The sharp increase in debt-to-equity materially raises financial risk compared with prior years. Greater leverage can reduce flexibility, increase the burden on future cash flows, and constrain the company’s ability to fund expansion or absorb weaker operating performance.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Revenue expanded strongly from 2023 to 2025, including a sharp step-up in 2025. This indicates meaningful business growth and can strengthen operating scale, reinvestment capacity, and competitive position over the next several quarters, provided the higher growth level is maintained.
Read all positive factors
Beauty Farm Medical & Health Industry, Inc. (2373) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$4.17B
Dividend Yield4.33%
Average Volume (3M)193.78K
Price to Earnings (P/E)8.8
Beta (1Y)0.58
Revenue Growth22.71%
EPS Growth43.58%
CountryHK
Employees6,975
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.60
Shares Outstanding251,593,720
10 Day Avg. Volume93,500
30 Day Avg. Volume193,783
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)5.54
Price to Sales (P/S)1.89
P/FCF Ratio6.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$31.43Price Target Upside61.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)1.79
Revenue Forecast (FY)HK$3.93B
Beauty Farm Medical & Health Industry, Inc. Business Overview & Revenue Model
Company Description
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty trea...
Beauty Farm Medical & Health Industry, Inc. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
56
Neutral
Cash Flow
62
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.42B | 3.00B | 2.57B | 2.15B | 1.64B | 1.78B |
| Gross Profit | 1.72B | 1.47B | 1.19B | 977.10M | 717.84M | 833.79M |
| EBITDA | 1.00B | 856.53M | 692.72M | 644.82M | 452.43M | 554.51M |
| Net Income | 384.04M | 317.56M | 228.46M | 215.66M | 103.11M | 193.47M |
Balance Sheet | ||||||
| Total Assets | 6.43B | 5.05B | 4.28B | 3.30B | 2.50B | 2.48B |
| Cash, Cash Equivalents and Short-Term Investments | 2.41B | 2.57B | 1.83B | 1.57B | 910.63M | 1.08B |
| Total Debt | 1.32B | 1.29B | 730.59M | 563.12M | 525.50M | 515.46M |
| Total Liabilities | 4.96B | 3.98B | 3.30B | 2.47B | 2.29B | 2.21B |
| Stockholders Equity | 1.41B | 1.02B | 944.64M | 801.90M | 188.75M | 257.36M |
Cash Flow | ||||||
| Free Cash Flow | 1.07B | 932.01M | 682.44M | 466.27M | 241.21M | 536.76M |
| Operating Cash Flow | 1.15B | 999.09M | 796.63M | 625.51M | 382.00M | 669.93M |
| Investing Cash Flow | -813.70M | -396.42M | -340.85M | -711.18M | 53.63M | -385.35M |
| Financing Cash Flow | -98.25M | 51.79M | -223.36M | 133.74M | -432.82M | -271.06M |
Beauty Farm Medical & Health Industry, Inc. Technical Analysis
Negative
19.49
Price Trends
18.03
Negative
17.76
Negative
19.62
Negative
Market Momentum
-0.51
Positive
40.44
Neutral
19.71
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2373, the sentiment is Negative. The current price of 19.49 is above the 20-day moving average (MA) of 17.33, above the 50-day MA of 18.03, and below the 200-day MA of 19.62, indicating a bearish trend. The MACD of -0.51 indicates Positive momentum. The RSI at 40.44 is Neutral, neither overbought nor oversold. The STOCH value of 19.71 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2373.
Beauty Farm Medical & Health Industry, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$4.17B | 8.81 | 31.63% | 4.33% | 22.71% | 43.58% | |
62 Neutral | HK$5.84B | 27.81 | 2.55% | 0.39% | 1.59% | -58.55% | |
54 Neutral | HK$62.39M | 3.94 | 12.17% | ― | 36.68% | ― | |
52 Neutral | HK$1.10B | 78.10 | 0.48% | 1.10% | -3.26% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$292.35M | -3.79 | -10.76% | 9.04% | -1.37% | -334.69% | |
48 Neutral | HK$1.03B | 31.06 | 1.27% | ― | ― | ― |
* Healthcare Sector Average
HK:2373
Beauty Farm Medical & Health Industry, Inc.
16.62
-12.95
-43.79%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.11
>-0.01
-5.08%
HK:3886
Town Health International Medical Group Ltd.
0.16
-0.11
-40.07%
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
9.51
-3.57
-27.33%
HK:6639
Arrail Group Ltd.
1.83
-0.06
-3.23%
HK:0722
UMP Healthcare Holdings Limited
0.37
-0.08
-17.61%
Beauty Farm Medical & Health Industry, Inc. Corporate Events
Beauty Farm Channels Idle Funds Into SPD Bank Wealth Products in Discloseable Deal
Oct 16, 2026
Beauty Farm Medical Health Industry Inc. has deployed idle cash into principal-guaranteed wealth management products issued by SPD Bank, subscribing RMB100 million on October 16, 2026 through Shanghai Yanze. These products follow earlier subscrip...
Beauty Farm deploys RMB300m idle cash into SPD Bank wealth products
Sep 17, 2026
Beauty Farm Medical and Health Industry Inc. has moved to optimize the use of idle cash by subscribing to principal-guaranteed wealth management products from SPD Bank through several mainland subsidiaries. The latest subscriptions on September 17...
Beauty Farm Medical & Health Industry Updates 2025 Final Dividend Payment
Aug 31, 2026
Beauty Farm Medical Health Industry Inc., a Hong Kong-listed provider of medical beauty and health services, caters to consumers seeking clinical and wellness treatments in the fast-expanding Asian aesthetic and healthcare market. The company lev...
Beauty Farm Posts Double-Digit Profit Growth on Surging Client Visits
Aug 27, 2026
Beauty Farm Medical and Health Industry Inc. reported strong interim results for the six months ended June 30, 2026, with client visits at direct stores rising 32.0% to about 1.21 million and revenue up 29.0% to RMB1.88 billion. Gross profit grew ...
Beauty Farm Sets Board Meeting and Earnings Call for 2026 Interim Results
Aug 13, 2026
Beauty Farm Medical and Health Industry Inc. has set August 27, 2026, as the date for a board meeting to review and approve its interim results for the six months ended June 30, 2026, and to consider whether to declare an interim dividend for shar...
Beauty Farm boosts Naturade footprint in Hangzhou with RMB10m acquisition
Aug 5, 2026
Beauty Farm Medical Health Industry Inc. has agreed to acquire 100% equity interests in Hangzhou Naturade Health Technology Company Limited and Hangzhou Xiaoshan Naturade Medical Beauty Clinic Co., Ltd. The transaction, valued at RMB10 million, w...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.